Short-term clinical effect of conformal radiotherapy combined with tegafur gimeracil oteracil potassiumin treating recurrent esophagus cancer
| Autor: | Hua Yan, Jian-Zhe Li, Yu-Zhen Shen, Yu-Yan Jiao, Yan Liu, Haihua Tan |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Tegafur Gimeracil Oteracil Potassium Urology 03 medical and health sciences 0302 clinical medicine medicine Tegafur-gimeracil-oteracil Potassium Esophagus Adverse effect Survival rate Chemotherapy Radiotherapy business.industry Cancer General Medicine medicine.disease Esophagus cancer Surgery Radiation therapy medicine.anatomical_structure 030220 oncology & carcinogenesis Original Article 030211 gastroenterology & hepatology Recurrent Esophagus Cancer business |
| Zdroj: | Pakistan Journal of Medical Sciences |
| ISSN: | 1681-715X |
| DOI: | 10.12669/pjms.325.10632 |
| Popis: | Objective: To observe clinical effects of three-dimensional conformal radiotherapy combined with Tegafur Gimeracil Oteracil Potassium chemotherapy in the treatment of patients with recurrent esophagus cancer. Methods: One hundred and twelve senile patients who suffered from esophagus cancer were selected and randomly divided into two groups, namely, observation group (56 cases) and control group (56 cases). The observation group adopted three-dimensional conformal radiotherapy combined with Tegafur Gimeracil Oteracil Potassium chemotherapy and the control group adopted three-dimensional conformal radiotherapy only. Results: All patients completed the treatment, with good compliance. Effective rate of the observation group was 82.1%, which was significantly higher than the control group (67.9%), and the difference was statistically significant (P0.05). The one-year and two-year survival rates of patients of the observation group were 80.4% and 53.6%, respectively, while the control group was 55.4% and 30.4%; differences between two groups were statistically significant (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|